• Year

    2025

    Value

    Not disclosed

    Sector

    Life Science

    Sale of 100% stake in MyBestPharm S.A. to Urgo Sp. z o. o.

    Saski Partners, part of Corporate Finance International, acted as the sole financial adviser to the shareholder of MyBestPharm S.A. on the sale of 100% stake to Urgo Sp. z o. o.

    Founded in 2021, MyBestPharm S.A. is a leading digitally native Polish brand specializing in premium food supplements, functional foods, and dermocosmetics. In just four years, the company has built a strong product portfolio distinguished by sophisticated formulations, high active ingredient dosages, and rigorous testing. Its bestsellers include MyBestBeauty+, MyBestProtect, and MyBestComplement. With the support of Urgo Healthcare, MyBestPharm plans to accelerate its growth both in Poland and internationally, targeting a doubling of turnover by 2030.

    Urgo Healthcare, part of the French family-owned Urgo Group, is a major player in everyday healthcare, known for iconic brands such as Urgo, Alvityl, Humer, and Belloc. As a leader in primary care, food supplements, and hygiene, Urgo Healthcare continues to strengthen its European footprint, with Poland being one of its most dynamic markets.

A LEADING CORPORATE FINANCE
ADVISOR, OFFERING A BRIDGE
BETWEEN POLAND
AND INTERNATIONAL MARKETS

corporate finance · mergers and acquisitions · fundraising · financial restructuring · strategic financial advice · equity financing · debt financing · private equity · private debt · refinancing · estate planning · family office · company strategy · company disposal · company purchase · financial model · valuation · issued shares · bond issue · leveraged buyote · management buyout